Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 590 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Diagnostic Ultrasound System Clear all

Conditions: Schizophrenia, Schizophrenia Schizoaffective
Interventions: PLIFUS, Sham PLIFUS, MRI; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 50 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Brooklyn, New York • New York, New York

Conditions: Prostate Cancer, Prostate Adenocarcinoma, Multiparametric MRI, Gleason's Score 6
Interventions: TRUS-guided biopsy, mpMRI with targeted biopsy; Procedure
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 40 Years and older · Male only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Breast Cancer Prevention, Mammographic Density
Interventions: Ultrasound-guided core needle biopsy, Denosumab, Blood draw, Calcium, Vitamin D; Procedure · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 35 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity
Interventions: Sonosite S-Nerve® US system (SonoSite, Bothell,WA); Device
Lead sponsor: Manuel C. Vallejo; Other
Eligibility: 14 Years to 55 Years · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Polycystic Ovary Syndrome, Infertility, Female
Interventions: May Health System; Device
Lead sponsor: May Health; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 19
States / cities: Encino, California • San Francisco, California • Tampa, Florida + 16 more

Conditions: Coronary Artery Disease, Atherosclerosis
Interventions: NIRS-IVUS Imaging (TVC Imaging System); Device
Lead sponsor: Infraredx; Industry
Eligibility: Not listed
Enrollment: 1,563 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 31
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Atlantis, Florida + 25 more

Conditions: Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver
Interventions: Ultrasound based shear wave speed and fat quantification methods, Blood collection, Physical measurements, Clinical history and medication reviews; Device · Diagnostic Test · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: San Diego, California • Boston, Massachusetts

Conditions: Hip Osteoarthritis, Primary Total Hip Arthroplasty, Pain
Interventions: Suprainguinal fascia iliaca (SIFI) block, Sham block, Ropivacaine, Saline; Procedure · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Labor Pain, Cesarean Delivery Regional Anesthesia Induction
Interventions: Ultrasound placement device; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pancreatic Cancer
Interventions: IRE + intratumoral mitazalimab (CD40 antibody) injection, NanoKnife; Drug · Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Physiology of Manipulation / Mobilization in Healthy Adults
Interventions: Spinal Manipulation, Spinal Mobilization, Sham Ultrasound; Other
Lead sponsor: Mount St. Mary's College, Los Angeles, CA; Other
Eligibility: 18 Years to 55 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
Interventions: Microwave Ablation; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 5
States / cities: Duarte, California • Rochester, Minnesota • New York, New York + 2 more

Conditions: COVID-19-Induced Parosmia
Interventions: Stellate Ganglion Block, Placebo Sham Injection; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hydrocephalus
Interventions: FlowSense; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Year to 21 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hemostasis, Blood Biomarkers, Ultrasound
Interventions: Ultrasound Pulsed Doppler Imaging System; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 50 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Cancer, Childhood Cancer
Interventions: Uroflow testing, Bladder Scan, Dysfunctional Voiding Scoring System Survey, DEXA Scan of pelvis and sacral spine, Urine tests for specific biomarkers; Diagnostic Test · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 2 Years to 40 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Embolic Stroke of Undetermined Source, Transient Ischemic Attack, Right-To-Left Atrial Shunt, Patent Foramen Ovale
Interventions: NeuralBot Investigational System, Transthoracic Echocardiography (TTE); Diagnostic Test
Lead sponsor: NeuraSignal Inc dba NovaSignal; Industry
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Phoenix, Arizona • Portland, Oregon • Chattanooga, Tennessee + 3 more

Conditions: Prostate Cancer
Interventions: high-intensity focused ultrasound ablation; Procedure
Lead sponsor: Focus Surgery; Industry
Eligibility: 40 Years to 80 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pain, Pancreatic Adenocarcinoma, Ductal Adenocarcinoma
Interventions: High intensity focused ultrasound, HIFU; Procedure
Lead sponsor: CMED HIFU Development Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Capsular Contracture of Breast, Grade III
Interventions: Aspen(TM) Ultrasound System; Device
Lead sponsor: Nina Naidu; Individual
Eligibility: 22 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Abdominal Fat
Interventions: High Intensity Focused Ultrasound Device, Noninvasive Cryolipolysis Device; Device
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pain, Postoperative, Root Canal Infection, Endodontically Treated Teeth
Interventions: GentleWave, Conventional Protocol; Other
Lead sponsor: University of Salamanca; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Manhattan, New York

Conditions: Prostate Cancer
Interventions: 3-D TRUS navigation software during T-RALP; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 35 Years to 75 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Skin Laxity
Interventions: Ulthera® System, Sculptra®, Sculptra® treatment followed by Ultherapy™ treatment; Device · Drug · Other
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 35 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca

RANKL Inhibition and Breast Tissue Biomarkers

A Novel Way to Estimate Epidural Depth in Morbidly Obese Parturient

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

The Lipid-Rich Plaque Study

Noninvasive Biomarkers of Metabolic Liver Disease 1.1

Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty

Neuraxial Ultrasound Device Study

Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer

A Study of the Effects of Mid-Thoracic Spinal Manipulation and Spinal Mobilization on Heart Rate Variability

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

Stellate Ganglion Block for COVID-induced Parosmia

EVD Drainage Data and Intracranial Pressure (ICP) Measurements

Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.

Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate

High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain

Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture

A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction

Effectiveness of GentleWave System in Endodontic Treatment

Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy

Ultherapy™ Treatment Following Sculptra® Treatment